The five deals that mattered most on 6 November 2026 across AI, space and biopharma, and what each one means, followed by every other verified deal of the day by sector. Every item links to its original source.
Defence AI M&A · US · 5 Nov
Shield AI agrees to buy radar maker Echodyne for about $5.3B and raises $2.5B
Shield AI pays about $4.8B at closing, plus up to $500M if Echodyne meets performance targets. To fund the deal it raises a $1B Series H at a $28.8B post-money valuation, $1B in structured equity from Blackstone funds and $500M in debt led by JPMorgan. Echodyne builds electronically scanned radar used in more than 40 countries, and Shield AI plans to pair it with its Hivemind autonomy software for drone detection and tracking. Closing is expected in early 2027.
Why it matters: An AI autonomy company now has the balance sheet to buy the sensors it depends on. Shield AI was valued at $12.7B in March.
Source: Shield AI via PR Newswire
Space financing · US · 5 Nov
CesiumAstro raises a $730M Series D at a valuation above $4.5B
Janus Henderson led the round, joined by Insight Partners, Sands Capital, Sumitomo Corporation of Americas, Woven Capital (Toyota), Magnetar and others, with $100M in debt from US EXIM and JPMorgan on top. The money funds Synchronicity, a planned constellation of 737 AI-enabled satellites, after the company’s Element-1 mission succeeded in full. CesiumAstro has raised more than $1.2B in 2026, including a $470M Series C in February.
Why it matters: A supplier of satellite payloads is becoming a network operator, and public market investors lead the round.
Source: CesiumAstro
Robotics & physical AI financing · US · 5 Nov
Zipline raises $1.5B at a $21.5B valuation to build a nationwide drone delivery network
Paradigm, WCM Investment Management and Layer Global led the round, joined by Uber, Tiger Global, Fidelity, JPMorgan, ARK Invest and Salesforce Ventures. All of it is new capital for the company. Zipline plans to expand US manufacturing and hiring, and Walmart adds about 300 more delivery sites under a multiyear agreement.
Why it matters: Investors now price drone delivery as infrastructure. Zipline was in talks at about $20B in September, and its valuation nearly tripled in about ten months.
Source: Zipline
Biotech licensing · US / China · 4 Nov
Evommune licenses Hinova’s oral VAV1 molecular glue degrader in a deal worth up to $1.1B
Evommune pays $30M upfront, $20M in cash and $10M in pre-funded warrants, with up to $1.1B in milestones plus royalties. It gains worldwide rights outside Greater China to EVO570, an oral drug for autoimmune diseases. A mid-stage trial in rheumatoid arthritis is planned for 2027.
Why it matters: Another promising asset from China moves to a US company, and a small biotech pays part of the upfront in shares to win it.
Source: BioSpace
Humanoid robotics listing · US · 4 Nov
Agility Robotics completes its merger with Churchill Capital Corp XI and lists on Nasdaq
The combined company trades on Nasdaq under the ticker AGLT from 5 November. The deal values Agility’s existing equity at about $2.5B and was set to bring in about $465M in gross capital. Agility’s humanoid robot Digit already moves materials in customer warehouses, and the company plans larger deployments from 2027.
Why it matters: Investors now have a listed pure play on humanoid robots in the US.
Source: Agility Robotics
More deals of the day
Pharma & biotech
- bit.bio (Cambridge, UK) raises a $25M Series D from M&G Investments and Abcam founder Jonathan Milner, as demand for its programmed human cell models reaches record levels. 4 Nov. Source: bit.bio
MedTech
- Laza Medical (Los Gatos, US) raises up to $160M in a structured Series B led by GE HealthCare, to bring AI imaging into the cath lab. 4 Nov. Source: Laza Medical
- Boston Scientific gets up to $455M from Blackstone Life Sciences to co-fund its Vitalyst heart pump for patients with cardiogenic shock, in return for milestones and royalties. 2 Nov. Source: Blackstone
AI & semiconductors
- Sand.ai (Beijing) raises a $200M Series A+ co-led by Cornerstone Capital and Wangsu Science & Technology, for its video foundation models. 5 Nov. Source: Pedaily
- Ocient (Chicago) raises a $100M Series C led by BOKA Capital and OCA Ventures, for AI analytics on petabyte-scale data. 5 Nov. Source: AIwire
- Bangxin Semiconductor (Shanghai) raises more than RMB 600M in a Series B+ led by Jiangxia Science and Technology Investment Group, for wafer etching and thin film deposition equipment. 5 Nov. Source: Pedaily
- Huayi Yingfei Photonics (Beijing) raises several hundred million yuan in a Series A co-led by a China Reform Holdings fund and Huakong Fund, for photonic chips in optical communications. 5 Nov. Source: Pedaily
- Jushi Technology (Shanghai) raises several hundred million yuan in a Series C from Caitong Capital and others, for AI inspection systems in chip manufacturing. 5 Nov. Source: Pedaily
Energy, planet & space
- VÆRIDION (Munich) raises a €30M Series A2 led by SHIFT Invest and Invest-NL for its nine-seat battery electric Microliner, and is selected for a €94.5M EU Innovation Fund grant. 5 Nov. Source: VÆRIDION
- FluoRok (Oxford, UK) raises a $30M Series A led by the Orano Venture Fund (Supernova Invest), for fluorochemicals made without hydrogen fluoride, including battery electrolyte salts. 5 Nov. Source: FluoRok
- Uranium Digital (New York) raises a $16.5M Series A led by Blockchain Capital, for its electronic trading platform for uranium. 5 Nov. Source: Fortune
Every earlier day is in the Deals archive.
More news, conversations and analysis on The Briefing.
For information only. Not investment advice.